Depacon (Valproate Sodium) - News

News related to Depacon (Valproate) and/or conditions it is approved for

Pfizer Receives FDA Approval For Geodon(R) (Ziprasidone HCI) Capsules For The Adjunctive Maintenance Treatment Of Bipolar Disorder In Adults
Source: Health News from Medical News Today [2009.11.23]
Pfizer announced that the U.S. Food and Drug Administration (FDA) has approved Geodon® (ziprasidone HCI) Capsules for maintenance treatment of bipolar I disorder as an adjunct to lithium or valproate in adults.

Ziprasidone Okayed for Bipolar Disorder
Source: MedPageToday.com - medical news plus CME for physicians [2009.11.23]
The FDA has approved another antipsychotic agent (MedPage Today) -- ziprasidone (Geodon) -- for maintenance treatment of bipolar I disorder as an adjunct to lithium or valproate.